Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
Journal Information
Full Title: J Hematol Oncol
Abbreviation: J Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"all raw rna-seq data are publicly available in national center for biotechnology information sequence read archive under accession number prjna837188."
"Declarations Ethics approval and consent to participateThe animal operations in this study were evaluated and approved by the Institutional Animal Care and Use Committee of Tongji Hospital of Huazhong University of Sciences and Technology. Consent for publicationNot applicable. Competing interestsJZ, YY, and PZ were employees of Wuhan YZY Biopharma Co., Ltd. Competing interests JZ, YY, and PZ were employees of Wuhan YZY Biopharma Co., Ltd."
"Funding This work was supported by the National Natural Science Foundation of China (No. 81874120, No. 82073370, No.82272794, No.62131009, and No.82072597)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025